Loading...

Verona Pharma plc

VRNANASDAQ
Healthcare
Biotechnology
$104.86
$0.09(0.08%)

Verona Pharma plc VRNA Peers

See (VRNA) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
VRNA$104.86+0.08%8.9B-52.42-$2.00N/A
VRTX$470.41-1.79%123.2B-125.89-$3.81N/A
REGN$563.67+2.01%59.4B14.22$39.36+0.31%
SGEN$228.74-0.07%43.2B-57.19-$4.00N/A
ALNY$315.93-1.54%42.1B-153.69-$2.10N/A
ARGX$561.57+1.15%34.4B34.37$16.39N/A
BNTX$112.75+0.87%27.4B-30.31-$3.76N/A
RPRX$35.83-0.13%20.3B14.74$2.45+2.95%
BGNE$184.71+0.49%20.2B-22.55-$8.19N/A
SMMT$25.09+1.41%19.2B-76.19-$0.34N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

VRNA vs VRTX Comparison

VRNA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, VRNA stands at 8.9B. In comparison, VRTX has a market cap of 123.2B. Regarding current trading prices, VRNA is priced at $104.86, while VRTX trades at $470.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

VRNA currently has a P/E ratio of -52.42, whereas VRTX's P/E ratio is -125.89. In terms of profitability, VRNA's ROE is -0.90%, compared to VRTX's ROE of -0.06%. Regarding short-term risk, VRNA is less volatile compared to VRTX. This indicates potentially lower risk in terms of short-term price fluctuations for VRNA.

Stock Price Comparison

Loading...

Frequently Asked Questions

;